Polysaccharide mycophenolate-based nanoparticles for enhanced immunosuppression and treatment of immune-mediated inflammatory diseases

Conclusion: Our results indicated the polysaccharide mycophenolate-based NPs to be highly promising for IMID treatment.

Source: Theranostics - April 19, 2021 Category: Molecular Biology Authors: Yuce Li, Yuchen Lou, Yu Chen, Jing Yang, Danqi Li, Biling Jiang, Jiajia Lan, Jingjing Wen, Yangxue Fu, Yamin Zhang, Juan Tao, Jintao Zhu Tags: Research Paper Source Type: research